Federation des caisses Desjardins du Quebec’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1K	Hold	300	–	–	﹤0.01%	2405
2026 Q1	$8.71K	Hold	300	–	–	﹤0.01%	2365
2025 Q4	$7.86K	Hold	300	–	–	﹤0.01%	2329
2025 Q3	$7.08K	Hold	300	–	–	﹤0.01%	2368
2025 Q2	$6.15K	Hold	300	–	–	﹤0.01%	2202
2025 Q1	$6.15K	Hold	300	–	–	﹤0.01%	2118
2024 Q4	$6.79K	Hold	300	–	–	﹤0.01%	2003
2024 Q3	$7.38K	Hold	300	–	–	﹤0.01%	1982
2024 Q2	$6.94K	Hold	300	–	–	﹤0.01%	1891
2024 Q1	$7.22K	Hold	300	–	–	﹤0.01%	1883
2023 Q4	$6.9K	Hold	300	–	–	﹤0.01%	1840
2023 Q3	$6.11K	Hold	300	–	–	﹤0.01%	1868
2023 Q2	$7.01K	Hold	300	–	–	﹤0.01%	1841
2023 Q1	$6.98K	Hold	300	–	–	﹤0.01%	1841
2022 Q4	$7.55K	Hold	300	–	–	﹤0.01%	1942
2022 Q3	$7.92K	Hold	300	–	–	﹤0.01%	1970
2022 Q2	$8.67K	Hold	300	–	–	﹤0.01%	1996
2022 Q1	$10.3K	Hold	300	–	–	﹤0.01%	2011
2021 Q4	$13.1K	Hold	300	–	–	﹤0.01%	1962
2021 Q3	$15.2K	Buy	+300	New	+$15.6K	﹤0.01%	1934

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's IDNA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q2 2026 at 300 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Federation des caisses Desjardins du Quebec first reported a position in IDNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $15.2K in Q3 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Federation des caisses Desjardins du Quebec held 300 shares of iShares Genomics Immunology and Healthcare ETF worth $10.1K as of Q2 2026.
Federation des caisses Desjardins du Quebec left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2405 holding.
Federation des caisses Desjardins du Quebec first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2021 and has held it in 20 quarters since.
Federation des caisses Desjardins du Quebec's iShares Genomics Immunology and Healthcare ETF position peaked at $15.2K in Q3 2021.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.